retatrutide release date 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide for Weight Loss: TRIUMPH-1

Wegovy is currently the only form of semaglutide thats FDA-approved for weight loss

Safe, Proven Results with GLP-1 Injections: Semaglutide and Tirzepatide (GLP-1 medications) are clinically proven to reduce hunger, improve insulin sensitivity, and support sustainable fat loss

If you miss your GLP-1 injection, take it as soon as you remember but only if its at least 3 days before your next scheduled dose

For an eligible patient, coverage may make treatment more affordable

The strong clinical data could drive increased product adoption and potentially expand the market for GLP-1-stimulating products beyond current offerings

We will get to all of that, but lets cover a bit of background first: what it is and how it can help you lose weight